Donald W. W. Newling

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck et al. · European Urology · 2006 · 3K citations

Medicine, Oncology, Urology +10

Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

Maurizio Brausi, Laurence Collette, Karl‐Heinz Kurth et al. · European Urology · 2002 · 683 citations

Medicine, Surgery, Urology +10

Preventing recurrence and progression in superficial bladder cancer

Donald W. W. Newling · Current Opinion in Urology · 1996 · 33 citations

Medicine, Oncology, Urology +13

Combination 186Re-HEDP and cisplatin supra-additive treatment effects in prostate cancer cells.

Albert A. Geldof, Laurens de Rooij, Richard T. Versteegh et al. · PubMed · 1999 · 22 citations

Medicine, Oncology, Pharmacology +15

Response of PC-3 prostate cancer cells to combination therapy using irradiation with glucocorticoids or doxorubicin.

Adrian Kruit, Carlos Reyes‐Moreno, Donald W. W. Newling et al. · PubMed · 2000 · 14 citations

Medicine, Oncology, Pharmacology +17